Lek trumps plans in 2018, employs additional 370 people
Ljubljana, 30 January - The Slovenian pharmaceutical company Lek, a subsidiary of the Swiss giant Novartis, has announced that it had a very successful 2018 compared to the set objectives, while failing to reveal concrete business results. It did say that it employed an additional 370 people last year to increase the workforce to 4,085.
The rest of this news item is available to subscribers.
The news item consists of 1.145 characters (without spaces) or 216 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.